| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(98)00177-4 |
| P698 | PubMed publication ID | 9862172 |
| P50 | author | Raymond M. Schiffelers | Q39472386 |
| P2093 | author name string | Suckling KE | |
| Groot PH | |||
| Benson GM | |||
| Toseland CD | |||
| Latcham J | |||
| Nicols C | |||
| Vidgeon-Hart M | |||
| P2860 | cites work | Molecular genetics of the LDL receptor gene in familial hypercholesterolemia | Q28207758 |
| Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia | Q34340579 | ||
| Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros | Q34360883 | ||
| Quantitative assessment of atherosclerotic lesions in mice | Q36456167 | ||
| Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice | Q37368611 | ||
| Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia | Q38672462 | ||
| An overview of the biochemical pharmacology of probucol | Q40042250 | ||
| The role of oxidized lipoproteins in atherogenesis | Q41043422 | ||
| The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia | Q49238390 | ||
| Non-macrophage-related accumulation of cholesterol during probucol treatment in familial hypercholesterolemia: report of two cases | Q68211339 | ||
| Mode of action of probucol in reducing serum cholesterol in mice | Q70033722 | ||
| Electrocardiographic effects of probucol. A controlled prospective clinical trial | Q70388418 | ||
| Factors related to QT interval prolongation during probucol treatment | Q70493620 | ||
| Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure | Q71231771 | ||
| Synthesis and hypocholesterolemic activity of alkylidenedithio bisphenols | Q71525007 | ||
| Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis | Q71799126 | ||
| Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice | Q72025026 | ||
| Enhancement of aortic cholesterol deposition by dietary linoleic acid in cholesterol-fed mice: an animal model for primary screening of antiatherosclerotic agents | Q72767806 | ||
| P433 | issue | 2 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 237-247 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice | |
| P478 | volume | 141 |
| Q33709262 | Antiatherosclerotic activity of drugs in relation to nitric oxide function |
| Q35570422 | Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice |
| Q33855324 | Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. |
| Q33237890 | Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies |
| Q44837169 | Porous aerosil loading probucol using supercritical carbon dioxide: preparation, in vitro and in vivo characteristics |
| Q34036818 | Potential role of oxidized lipids and lipoproteins in antioxidant defense. |
| Q35163535 | Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse |
Search more.